Literature DB >> 28068327

CIP2A confirms its prognostic value in triple-negative breast cancer.

I Cristóbal1, S Zazo2, B Torrejón1, M Pedregal1, J Madoz-Gúrpide2, A Lluch3, P Eroles3, A Rovira4, J Albanell4, J García-Foncillas1, F Rojo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28068327     DOI： 10.1038/onc.2016.474

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  4 in total

1.  Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1.

Authors:  H Liu; H Qiu; Y Song; Y Liu; H Wang; M Lu; M Deng; Y Gu; J Yin; K Luo; Z Zhang; X Jia; G Zheng; Z He
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

2.  CIP2A is associated with human breast cancer aggressivity.

Authors:  Christophe Côme; Anni Laine; Maïa Chanrion; Henrik Edgren; Elina Mattila; Xiaoling Liu; Jos Jonkers; Johanna Ivaska; Jorma Isola; Jean-Marie Darbon; Olli Kallioniemi; Simon Thézenas; Jukka Westermarck
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

3.  PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects.

Authors:  Raúl Rincón; Ion Cristóbal; Sandra Zazo; Oriol Arpí; Silvia Menéndez; Rebeca Manso; Ana Lluch; Pilar Eroles; Ana Rovira; Joan Albanell; Jesús García-Foncillas; Juan Madoz-Gúrpide; Federico Rojo
Journal:  Oncotarget       Date:  2015-02-28

4.  Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.

Authors:  Anni Laine; Harri Sihto; Christophe Come; Mathias T Rosenfeldt; Aleksandra Zwolinska; Minna Niemelä; Anchit Khanna; Edward K Chan; Veli-Matti Kähäri; Pirkko-Liisa Kellokumpu-Lehtinen; Owen J Sansom; Gerard I Evan; Melissa R Junttila; Kevin M Ryan; Jean-Christophe Marine; Heikki Joensuu; Jukka Westermarck
Journal:  Cancer Discov       Date:  2013-01-10       Impact factor: 39.397
  4 in total
  4 in total

1.  Cip2a/miR-301a feedback loop promotes cell proliferation and invasion of triple-negative breast cancer.

Authors:  Jiang Yin; Danyang Chen; Kai Luo; Minying Lu; Yixue Gu; Shanshan Zeng; Xiangzhou Chen; Ying Song; Zhijie Zhang; Guopei Zheng; Zhimin He; Hao Liu
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

2.  Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer.

Authors:  Wei Chen; Jing-Lin Liang; Kai Zhou; Qing-Li Zeng; Jun-Wen Ye; Mei-Jin Huang
Journal:  Cell Commun Signal       Date:  2020-04-22       Impact factor: 5.712

3.  Prognostic significance of CIP2A expression in solid tumors: A meta-analysis.

Authors:  Min Tang; Jiao-Feng Shen; Ping Li; Li-Na Zhou; Ping Zeng; Xi-Xi Cui; Min-Bin Chen; Ye Tian
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

4.  CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer.

Authors:  Melani Luque; Ion Cristóbal; Marta Sanz-Álvarez; Andrea Santos; Sandra Zazo; Pilar Eroles; Oriol Arpí; Ana Rovira; Joan Albanell; Juan Madoz-Gúrpide; Jesús García-Foncillas; Federico Rojo
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.